Inhibition of UDP-glucuronosyltransferases by fedratinib, implying a high risk of drug-drug interactions

Chemico-Biological Interactions 2026

View at publisher

Authors: Zhen Wang, Xin Lv, Hang Yin, Lili Jiang, Yuntao Ji, Xing Zhang, Changqing Qv, Yong Liu

DOI: 10.1016/j.cbi.2026.111994

Cited by: 1

References: 30

Fields of Study & Subjects

Pharmacogenetics and Drug Metabolism Colorectal Cancer Treatments and Studies HER2/EGFR in Cancer Research

References 30